Tender Joints Were Not Associated With Ultrasound-Detected Synovitis in RA
Researchers found data from a large longitudinal study using comprehensive ultrasound examination.
Home
Baricitinib Monotherapy May Improve Rheumatoid Arthritis Disease Activity
Researchers found data that showed baricitinib reduces disease activity in patients with rheumatoid arthritis.
Achieving ASAS40 Improves Patient-Reported Outcomes in Ankylosing Spondylitis
Patients with ankylosing spondylitis who achieve the ASAS40 end point have less spinal pain at night, less fatigue, better sleep, and improved quality of life.
Easily Acquired Data Can Predict Knee Osteoarthritis in High-Risk Patients
Among people with a high risk for knee OA, the increased risk for incident functional impairment can be evaluated using easily acquired data.
Reviewing the Safety of Chronic Paracetamol Use for Osteoarthritis Pain
The use of paracetamol for the management of osteoarthritis pain should be further investigated, as the drug may only provide low analgesic benefits, be associated with adverse events, and be toxic at higher doses.
Musculoskeletal Pain Intensity Associated With Greater Healthcare Utilization
Higher pain intensity may be associated with more condition-specific healthcare utilization and the use of opioids in patients with musculoskeletal pain.
Risk for Leg Amputation Higher With Microvascular Disease
Microvascular disease (MVD) increases the risk for amputation alone and in combination with peripheral artery disease.
Prescribing Fewer Tablets Can Cut Post-ACL Surgery Opioid Use
For patients undergoing anterior cruciate ligament reconstruction, prescribing fewer tablets is associated with lower postoperative opioid consumption.
An Exploration of Pharmacogenomics in Rheumatoid Arthritis
Researchers found that using genes as biomarkers to identify the optimal therapy might potentially someday benefit patients with rheumatoid arthritis.
No Increase in Malignancies, Infections for Abatacept vs Other DMARDs
Researchers found data that were consistent across randomized controlled trials of abatacept, but they believe that further examination of observational studies could show the risks of treatment with abatacept.
Want to read more?
Please login or register first to view this content.
Next post in Rheumatoid Arthritis Advisor
